ProShare Advisors LLC - FIVE PRIME THERAPEUTICS INC ownership

FIVE PRIME THERAPEUTICS INC's ticker is FPRX and the CUSIP is 33830X104. A total of 171 filers reported holding FIVE PRIME THERAPEUTICS INC in Q2 2016. The put-call ratio across all filers is 12.90 and the average weighting 0.1%.

Quarter-by-quarter ownership
ProShare Advisors LLC ownership history of FIVE PRIME THERAPEUTICS INC
ValueSharesWeighting
Q1 2021$552,000
+130.0%
14,662
+3.9%
0.00%
+100.0%
Q4 2020$240,000
+344.4%
14,113
+1.6%
0.00%
Q3 2019$54,000
-36.5%
13,884
-1.4%
0.00%
-100.0%
Q2 2019$85,000
-59.5%
14,076
-10.4%
0.00%0.0%
Q1 2019$210,000
+44.8%
15,702
+1.0%
0.00%0.0%
Q4 2018$145,000
-44.0%
15,548
-16.5%
0.00%
-50.0%
Q3 2018$259,000
-14.5%
18,612
-2.9%
0.00%0.0%
Q2 2018$303,000
-13.2%
19,167
-5.7%
0.00%0.0%
Q1 2018$349,000
-18.8%
20,324
+3.6%
0.00%
-33.3%
Q4 2017$430,000
-42.0%
19,623
+8.1%
0.00%
-57.1%
Q3 2017$742,000
+43.5%
18,149
+5.7%
0.01%
+40.0%
Q2 2017$517,000
-23.0%
17,177
-7.5%
0.01%
-28.6%
Q1 2017$671,000
-42.1%
18,562
-19.7%
0.01%
-46.2%
Q4 2016$1,159,000
+5.6%
23,123
+10.5%
0.01%
-13.3%
Q3 2016$1,098,000
+9.4%
20,918
-13.9%
0.02%
+15.4%
Q2 2016$1,004,000
+6.8%
24,290
+5.0%
0.01%0.0%
Q1 2016$940,000
-10.9%
23,137
-9.0%
0.01%0.0%
Q4 2015$1,055,000
+214.9%
25,418
+16.9%
0.01%
+160.0%
Q3 2015$335,000
-41.9%
21,736
-6.4%
0.01%
-37.5%
Q2 2015$577,000
+4.7%
23,217
-3.7%
0.01%
+33.3%
Q1 2015$551,000
+13.6%
24,115
+34.2%
0.01%0.0%
Q4 2014$485,00017,9740.01%
Other shareholders
FIVE PRIME THERAPEUTICS INC shareholders Q2 2016
NameSharesValueWeighting ↓
BVF INC/IL 6,338,678$238,778,0008.95%
One Fin Capital Management LP 440,000$16,575,0006.37%
COMMODORE CAPITAL LP 361,344$13,612,0005.42%
Chicago Capital Management, LLC 295,864$11,145,0005.19%
Kellner Capital, LLC 226,876$8,546,0003.10%
HARVEST MANAGEMENT LLC 97,500$3,673,0002.20%
Rock Springs Capital Management LP 2,660,822$100,233,0002.19%
ALPINE ASSOCIATES MANAGEMENT INC. 2,007,700$75,630,0002.05%
NEXPOINT ASSET MANAGEMENT, L.P. 198,278$7,469,0001.95%
GARDNER LEWIS ASSET MANAGEMENT L P 236,565$8,911,0001.60%
View complete list of FIVE PRIME THERAPEUTICS INC shareholders